Review
Published on 09 May 2024
O-GlcNAcylation in ischemic diseases
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1377235
Type at least 3 characters
1,112 articles
Articles
Original Research
Accepted on 03 May 2024
Research trends in lipid-lowering therapies for coronary heart disease combined with hyperlipidemia: a bibliometric study and visual analysis
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1393333
Original Research
Published on 03 May 2024
Cardiovascular adverse events associated with antibody-drug conjugates (ADCs): a pharmacovigilance study based on the FAERS database
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1378010
- 283 views
Case Report
Published on 01 May 2024
Case report: Successful anesthesia management of noncardiac surgery in a patient with single atrium
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1370263
- 149 views
Review
Accepted on 29 Apr 2024
The structure and function of FUN14 domain-containing protein 1 and its contribution to cardioprotection by mediating mitophagy
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389953
Editorial
Published on 29 Apr 2024
Editorial: Recent advances in cardiotoxicity testing, volume II
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1414373
Case Report
Published on 26 Apr 2024
Ascorbic acid-induced warfarin resistance after breast cancer surgery: a case report and literature review
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1390996
- 197 views
Original Research
Published on 25 Apr 2024
Noninvasive cardiac-specific biomarkers for the diagnosis and prevention of vascular stenosis in cardiovascular disorder
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1376226
- 234 views
Review
Published on 24 Apr 2024
Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1396656
- 252 views
Review
Published on 18 Apr 2024
Non-coding RNAs as regulators of the Hippo pathway in cardiac development and cardiovascular disease
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1348280
- 268 views
Review
Accepted on 17 Apr 2024
Thromboembolic Prevention in Athletes: Management of Anticoagulation in Sports-players Affected by Atrial Fibrillation
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1384213
Review
Published on 12 Apr 2024
NLRP3 inflammasome and pyroptosis in cardiovascular diseases and exercise intervention
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1368835
- 456 views
Review
Published on 11 Apr 2024
The cardioprotective potential of selected species of mistletoe
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1395658
- 402 views
Original Research
Published on 09 Apr 2024
The biased apelin receptor agonist, MM07, reverses Sugen/hypoxia-induced pulmonary arterial hypertension as effectively as the endothelin antagonist macitentan
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1369489
- 467 views
Original Research
Accepted on 05 Apr 2024
Left Bundle Branch Pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1402782
Original Research
Published on 05 Apr 2024
GKT137831 and hydrogen peroxide increase the release of 6-nitrodopamine from the human umbilical artery, rat-isolated right atrium, and rat-isolated vas deferens
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1348876
- 514 views